NEESHA DESAI: Open Payments
NPI 1285838516 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 11 payments from 7 companies in 2025. Trend: 2023 $30 · 2024 $15 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| Janssen Pharmaceuticals, Inc | 1 | $40 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Tris Pharma Inc | 2 | $30 |
| ABBVIE INC. | 1 | $27 |
| Lundbeck LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: REXULTI, ABILIFY ASIMTUFII, INVEGA SUSTENNA, INGREZZA, Dyanavel XR, VRAYLAR, TRINTELLIX.
Industry payments across GA — which companies pay providers there.
